HISTORICAL FACTS: 16 - Caught on Camera

COVID-19 Vaccine Patent Waiver Expected Soon, Says WTO Head: Reuters

In a telephone interview with Reuters, WTO's Director-General Ngozi Okonjo-Iweala, an agreement on waiving intellectual property rights for COVID-19 vaccines is within reach. A key World Trade Organization (WTO) meeting is scheduled next week to discuss the COVID-19 vaccine patent waiver debate. "If we get one or two deliverables, that…

Benzinga · Jun 8, 2022

Do AI systems really have their own secret language?

A new generation of artificial intelligence (AI) models can produce “creative” images on-demand based on a text prompt. The likes of Imagen, MidJourney, and DALL-E 2 are beginning to change the way creative content is made with implications for copyright and intellectual property.

The Conversation · Jun 6, 2022

We still need a vaccine patent waiver, but not the one on offer at the World Trade Organization meeting

In mid-June, the World Trade Organization (WTO) will meet to finish negotiations to waive certain sections of the agreement on Trade Related Intellectual Property Rights (TRIPS). However, it is not the TRIPS waiver originally proposed 18 months ago by member states South Africa and India, which would have allowed countries…

The Conversation · Jun 5, 2022

NGOs urge Biden to push for changes to WTO's COVID waiver text

Oxfam America, Partners in Health and other civil society groups urged U.S. President Joe Biden to press for changes in a draft agreement on waiving intellectual property rights for COVID-19 vaccines, underscoring divisions over the current text.

Reuters · May 24, 2022

Mirum Pharma Acquires Its Licensing Partner In Cash and Stock

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) has acquired Satiogen Pharmaceuticals Inc in a cash and stock deal. The deal consideration includes 841,792 shares, 199,993 of which are subject to the achievement of a milestone, and approximately $2.8 million in cash.  Mirum will wholly own the Satiogen subsidiary, which will receive a 2% royalty. Satiogen was an…

Benzinga · May 23, 2022

AgriFORCE Completes Acquisition Of Intellectual Property From Manna Nutritional

AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) has completed the previously announced acquisition of the intellectual property (IP) of Manna Nutritional Group (MNG). The IP encompasses patent-pending technologies to naturally process and convert grain, pulses, and root vegetables, resulting in low-starch, low-sugar, high-protein, fiber-rich baking flour products. The core process is covered under a pending patent application…

Benzinga · May 18, 2022

Australia risks relying on Pfizer and Moderna for its COVID vaccines. 3 ways to break free

The rapid development and deployment of COVID vaccines has been one of the greatest achievements of the pandemic.

The Conversation · May 15, 2022

Dr. Seuss working with bankers on value of lucrative IP

This is one of the most prized collections of intellectual property in the world.

Axios · May 10, 2022

Affordable Covid drugs kept out of reach by sluggish WTO

Analysis: EU and US pharma giants’ intellectual property rights stop poorer countries accessing vital medication – despite WTO claims of progress

The Guardian - UK · May 9, 2022

WTO meeting on COVID vaccine rights waiver went 'very well' -chair

The first World Trade Organization meeting to discuss a draft agreement to temporarily waive intellectual property rights for COVID-19 vaccines went "very well", its chair said on Friday, although some members voiced reservations.

Reuters · May 6, 2022